Variant report
Variant | esv14699 |
---|---|
Chromosome Location | chr4:130066164-130068470 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72928002 | chr4:130066204-130066205 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs183624352 | chr4:130066230-130066231 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562661619 | chr4:130066237-130066238 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561219413 | chr4:130066314-130066315 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530946955 | chr4:130066405-130066406 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112737247 | chr4:130066408-130066409 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367890885 | chr4:130066502-130066503 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371737439 | chr4:130066511-130066512 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375919859 | chr4:130066519-130066520 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368949128 | chr4:130066524-130066525 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367840799 | chr4:130066643-130066644 | Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74631127 | chr4:130066679-130066680 | Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188330087 | chr4:130066931-130066932 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143361612 | chr4:130066939-130066940 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72929904 | chr4:130066985-130066986 | Active TSS Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs192273951 | chr4:130066991-130066992 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571750252 | chr4:130067041-130067042 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561614347 | chr4:130067061-130067062 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372805980 | chr4:130067062-130067063 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs58906057 | chr4:130067065-130067066 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112081684 | chr4:130067066-130067067 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201664315 | chr4:130067073-130067074 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150092976 | chr4:130067099-130067100 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569432815 | chr4:130067127-130067128 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536378967 | chr4:130067129-130067130 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12506190 | chr4:130067176-130067177 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs373068719 | chr4:130067185-130067186 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540251732 | chr4:130067205-130067206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185003704 | chr4:130067209-130067210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11098997 | chr4:130067253-130067254 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs544484837 | chr4:130067267-130067268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562587376 | chr4:130067287-130067288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143526046 | chr4:130067295-130067296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112195897 | chr4:130067298-130067299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561068419 | chr4:130067342-130067343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534561258 | chr4:130067365-130067366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs72929908 | chr4:130067441-130067442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11730162 | chr4:130067489-130067490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs189467124 | chr4:130067514-130067515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537350784 | chr4:130067650-130067651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs147227675 | chr4:130067652-130067653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551235697 | chr4:130067665-130067666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557262292 | chr4:130067666-130067667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569384125 | chr4:130067667-130067668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs397880595 | chr4:130067675-130067676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536851776 | chr4:130067706-130067707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182052860 | chr4:130067747-130067748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139850622 | chr4:130067822-130067823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533831468 | chr4:130067834-130067835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:130065800-130066200 | Active TSS | Adipose Nuclei | Adipose |
2 | chr4:130065800-130066200 | Bivalent Enhancer | Left Ventricle | heart |
3 | chr4:130065800-130066200 | Enhancers | HUVEC | blood vessel |
4 | chr4:130065800-130066200 | Flanking Active TSS | K562 | blood |
5 | chr4:130065800-130066400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr4:130065800-130066800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr4:130066000-130066400 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr4:130066200-130067200 | Active TSS | K562 | blood |
9 | chr4:130066400-130066600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr4:130066400-130067000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
11 | chr4:130066600-130066800 | Flanking Bivalent TSS/Enh | HepG2 | liver |
12 | chr4:130066600-130067000 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
13 | chr4:130067200-130068000 | Enhancers | K562 | blood |